安旭生物：股东拟减持不超0.94%公司股份

Core Viewpoint - Anxu Bio (688075) announced that its shareholder, Ma Huaxiang, who holds 11.62% of the company's shares, plans to reduce his holdings by up to 1.2 million shares, representing no more than 0.94% of the total share capital of the company, through centralized bidding transactions [1] Summary by Categories - Shareholder Reduction Plan - Ma Huaxiang intends to reduce his shareholding by up to 1.2 million shares [1] - The reduction will not exceed 0.94% of the company's total share capital [1] - The total number of shares reduced within any consecutive 90 natural days will not exceed 1% of the company's total shares [1]